Publications:

Monitoring EGFR-lung cancer evolution: a possible beginning of a "methylation era" in TKI resistance prediction.

Frontiers In Oncology

Fabrizio, Federico Pio FP; Sparaneo, Angelo A; Muscarella, Lucia Anna LA

Publication Date: 2023

Variant appearance in text: ALK: L868R

PubMed Link: 37152062

Variant Present in the following documents:

• Main text
• fonc-13-1137384.pdf

View BVdb publication page

NSCLC patients with rare EGFR Ex19del/G724S mutation showed good response to afatinib combined with chemotherapy treatment: A two-case report.

Frontiers In Oncology

Wang, Huilin H; Yu, Qitao Q; Shi, Lina L; Hou, Qinhan Q; Dan, Liang L; Liang, Chuqiao C; Hong, Xiaoyu X; Zhao, Yun Y; Ning, Ruiling R

Publication Date: 2022

Variant appearance in text: ALK: L868R

PubMed Link: 36505860

Variant Present in the following documents:

• Main text
• fonc-12-1054593.pdf

View BVdb publication page

[A Real-world Study on the Assessment of Pathological Characteristics and Targeted Therapeutic Effect of Non-small Cell Lung Cancer Patients with Positive Driving Genes and High PD-L1 Expression].

Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer

Zhang, Hui H; Yang, Xinjie X; Li, Kun K; Wang, Jinghui J; Lv, Jialin J; Li, Xi X; Zhang, Xinyong X; Qin, Na N; Zhang, Quan Q; Wu, Yuhua Y; Ma, Li L; Gai, Fei F; Hu, Ying Y; Zhang, Shucai S

Publication Date: 2021-02-20

Variant appearance in text: ALK: L868R

PubMed Link: 33478196

Variant Present in the following documents:

• zgfazz-24-2-78.pdf

View BVdb publication page

The resistance mechanisms and treatment strategies for EGFR-mutant advanced non-small-cell lung cancer.

Oncotarget

Zhong, Wen-Zhao WZ; Zhou, Qing Q; Wu, Yi-Long YL

Publication Date: 2017-09-19

Variant appearance in text: ALK: L868R

PubMed Link: 29050366

Variant Present in the following documents:

• Main text
• oncotarget-08-71358.pdf

View BVdb publication page